My interpretation/understanding is that it is only the issue of options to RCP that is dependent on shareholder approval. That is planned for June. See below.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game